Background: Pyridoxine (VB 6 ), which acts as a coenzyme in the biosynthesis of nia-
| INTRODUC TI ON
To date, pyridoxine (VB 6 ) has been commonly formulated in pharmaceuticals used to treat skin roughness. However, the pharmacological mechanism involved has not been clarified precisely. On the other hand, oxidative stress induced by excess reactive oxygen species (ROS) can lead to various skin disorders. The skin is constantly exposed to ROS initiators, such as sunlight, chemicals and air pollution. [1] Sodium lauryl sulphate (SLS), which is an anionic surfactant, has been commonly used to cause skin roughness artificially. [2] In general, the mechanism by which SLS induces skin roughness has been understood to result from the disrupted barrier function in the stratum corneum (SC) due to the decomposition of intracellular lipid lamellar structures. [3, 4] However, in a previous study, we demonstrated that SLS, which penetrates to living cell layers of the epidermis, elevates intracellular ROS levels by increasing intracellular Ca 2+ levels due to structural alterations of the cell membrane. [5] Decreasing skin moisture functions, such as impaired skin barrier function and lower skin surface water content, are typical characteristics of skin roughness. In fact, the SC of dry skin shows higher levels of carbonylated proteins (CPs), which are synthesized by reactions initiated by ROS, than those found in the SC of normal skin.
In addition, it has been reported that a higher ratio of IL-1RA/IL-1α is observed in dry skin and in artificially dry skin produced by treatment with SLS. [6, 7] That phenomenon indicated that high amounts of IL-1α are secreted from keratinocytes in the dry skin. IL-1α also stimulates ROS generation through interleukin-1 receptor-associated kinase-1 (IRAK-1). [8] The sum of these facts leads to the hypothesis that the exposure of skin to highly oxidative conditions triggers skin roughness.
VB 6 was initially discovered as an anti-inflammatory factor. [9] In general, VB 6 serves as a coenzyme for enzymes involved in amino acid metabolism and nutrition. [10] In addition, recent studies have further clarified the effects of VB 6 to also be involved in the regulation of hormone synthesis, [11] the quenching of singlet oxygen, [12] anti-cancer effects [13] and the detoxification of activated CPs in diabetic patients. [14] Since VB 6 acts as a coenzyme in the biosynthesis of niacin, it was consequently expected to increase the antioxidant capacity of cells due to increases of NADH or NADPH, which are co-factors of antioxidant enzymes such as glutathione reductase and thioredoxin reductase.
This study was conducted to clarify the relationship between highly oxidative conditions and skin roughness and to demonstrate the nature of the pharmacological effects of VB 6 .
| ME THODS

| Reagents
Normal human epidermal keratinocytes (NHEKs, KK-4009) and
HuMedia-KG2 culture medium were purchased from Kurabo Industries Ltd. (Osaka, Japan). Buthionine sulfoximine (BSO), glutathione and pyridoxine hydrochloride were purchased from Nacalai 
| Cell culture
Normal human epidermal keratinocytes were cultured in
HuMedia-KG2 at 37°C in a humidified atmosphere containing 5% CO 2 . Cells were treated with appropriate concentrations of reagents in HuMedia-KG2. NHEKs in highly oxidative conditions were prepared by cultivation in HuMedia-KG2 containing 100 μmol/L BSO, which is a specific inhibitor of γ-glutamyl cysteine synthetase (γ-GCS).
[15] 
| Determination of CP levels
| Measurement of intracellular ROS levels
| Reduction of resazurin to resorufin
The amount of NADPH was estimated according to the F.I. of resorufin, the reduced form of resazurin, using the AlamarBlue 
| Quantification of total glutathione in cells
Total glutathione levels in cell lysates were measured using an assay based on the glutathione recycling system with DTNB reagent and glutathione reductase (GR). [16] NHEKs were lysed in 100 μL 0.5% Triton X100. Twenty-five microlitre of each cell lysate 
| Immunofluorescent microscopy of Nrf2
Normal human epidermal keratinocytes (5 × 10 3 cells/well) were seeded into 96-well plates in HuMedia-KG2 and were cultured for 24 hours. After incubation with VB 6 for 6 hours, cells were fixed with 4% formaldehyde and then were permeabilized with 0.2% Triton X100. After blocking with 1% BSA, 2 μg/mL rabbit anti-Nrf2 polyclonal antibody was used for immunofluorescent staining. To label antibody bound to Nrf2, 2 μg/mL donkey anti-rabbit IgG H&L 
| RNA analysis by Real-Time Quantitative RT-PCR
Total RNAs were harvested from cells using a Qiagen RNeasy kit and were then used for the synthesis of cDNAs using a ReverTra Ace qPCR RT kit according to the manufacturer's recommendations. Quantification of mRNA levels was carried out using an ECO Real-Time PCR system (Illumina, Inc., San Diego, CA, USA) and SYBR Green Real-Time PCR Master Mix (Thermo Fisher Scientific Inc.). The following primer sets for γ-GCS, Nrf2, SPT, GAPDH and β-actin were used: γ-GCS forward 5′-TTGCAGGAAGGCATTGATCA-3′ and reverse 5′-GCATCATCCAGGT GTATTTTCTCTT-3′, Nrf2 forward 5′-TTCTGTTGCTCAGGTAGCCCC-3′
and reverse 5′-TCAGTTTGGCTTCTGGACTTGG-3′, SPT forward 5′-TG GTCATTTGGCCCAGGTC-3′ and reverse 5′-TTCCAACCATTGGC TTCACATC-3′, GAPDH forward 5′-GCACCGTCAAGGCTGAGAAC-3′
and reverse 5′-TGGTGAAGACGCCAGTGGA-3′, β-actin forward 5′-TGGCACCCAGCACAATGAA-3′ and reverse 5′-CTAAGTCATAGTC CGCCTAGAAGCA-3′. Quantitative analysis of mRNA expression was performed from three replicates of untreated and treated cells. All mRNAs were normalized against the amplification of the housekeeping genes GAPDH or β-actin.
| Statistical analysis
All data are expressed as means ± SD. Comparisons between two groups were performed by Student's t test. A P-value of <0.05 is considered statistically significant.
| RE SULTS
| mRNA expression levels of skin moisturerelated genes and intracellular CPs in BSO-treated NHEKs
To clarify the influence of highly oxidative conditions on skin moisture-related genes, mRNA expression levels of SPT and filaggrin in NHEKs treated with BSO were examined. BSO-treated
NHEKs showed a significant down-regulation of SPT mRNA expression ( Figure 1A ), but there was no change in filaggrin mRNA expression ( Figure 1B) . Intracellular CPs were measured as a parameter of intracellular oxidative conditions. The intracellular CP level was significantly elevated by BSO treatment ( Figure 1C ). These results indicated that highly oxidative conditions induce the down-regulation of SPT and suggest the progression of impaired skin barrier function.
| Suppression of mRNA expression and intracellular oxidative conditions in NHEKs induced by BSO
Treatment with VB 6 restored the down-regulation of SPT mRNA expression in BSO-treated NHEKs (Figure 2A ). In addition,
NHEKs treated with VB 6 in the presence of BSO had reduced levels of intracellular CPs in a dose-dependent manner ( Figure 2B ).
Interestingly, VB 6 even reduced levels of intracellular CPs in NHEKs cultured in physiological conditions ( Figure 2B ). These results indicate that VB 6 increases intracellular defenses against highly oxidative conditions.
| Intracellular ROS, NADPH/NADH and total glutathione
In order to clarify whether VB 6 involves stimulation of the intracellular antioxidant system, the effects of VB 6 on intracellular ROS levels in NHEKs were measured. NHEKs treated with VB 6 for 24 hours showed a reduction in their intracellular ROS level ( Figure 3A ), which indicates that VB 6 enhances the intracellular antioxidant capability. To characterize the action of VB 6 on the intracellular antioxidant system, we then evaluated the amount of NADPH/NADH that is synthesized from niacin and functions as a coenzyme of reductases, and total glutathione as an intracellular oxidant. VB 6 significantly increased the amount of NADPH/NADH at concentrations of 250 μmol/L and higher ( Figure 3B ). On the other hand, the amount of total glutathione, which includes the reduced plus the oxidized forms, increased after treatment with VB 6 for 24 hours in a concentration-dependent manner ( Figure 3D ).
F I G U R E 2 Expression level of SPT mRNA and CP levels after treatment with VB 6 for 24 h following treatment with BSO.
Stimulation of the expression level of SPT mRNA by VB 6 following GSH depletion (A). NHEKs were treated with BSO at 100 μmol/L for 24 h, after which 100 μmol/L VB 6 in the absence or presence of 100 μmol/L BSO was added to the culture medium. After additional cultivation for 24 h, total RNAs were extracted from the cells and cDNAs were synthesized and analysed by RT-PCR. Data show relative mRNA expression levels of SPT normalized against β-actin. Data are reported as means ± SD (n = 3), **P < 0.01 differences with or without BSO treatment, ###P < 0.001 differences with or without VB 6 treatment (Student's t test). CP levels after treatment with VB 6 for 24 h following treatment with BSO (B). NHEKs were treated with BSO at 100 μmol/L for 24 h, after which VB 6 at 250-1000 μmol/L in the absence or presence of 100 μmol/L BSO was added to the culture medium. After incubation with VB 6 for 24 h, CPs and nuclei were detected with FTCZ (green) and Hoechst 33342 (blue), respectively. Data are reported as means ± SD (n = 5), ###P < 0.001 vs BSO(−)VB 6 (−), ***P < 0.001 vs BSO(+)VB 6 (−) (Student's t test) 
| Stimulating ability of the induction of γ-GCS via activation of the Nrf2 pathway
The process of de novo glutathione synthesis is regulated by two major enzymatic steps catalysed by γ-GCS and glutathione synthetase.
[17] VB 6 significantly up-regulated the mRNA expression level of γ-GCS, a rate-limiting enzyme of GSH synthesis, at 24 hours treatment ( Figure 3C ). In addition, VB 6 significantly upregulated the mRNA expression level of Nrf2 at 6 hours treatment ( Figure 4A ). At 6 hours treatment of VB 6 , it was also observed that the translocation of Nrf2 protein into the nucleus and the Nrf2 protein level was increased compared to untreated cells ( Figure 4B ).
| D ISCUSS I ON
VB 6 is one of the most common vitamins formulated in pharmaceuticals used to treat skin roughness. However, the precise mechanism F I G U R E 3 Effects of VB 6 on the intracellular antioxidant system in NHEKs. Intracellular ROS levels after treatment with VB 6 for 24 h (A).
NHEKs treated with VB 6 were incubated with 20 μmol/L H 2 DCFDA in HBSS(−) for 30 min. After washing with HBSS(−), the fluorescence was measured. Intracellular ROS levels were calculated as F.I. per μg protein. Data are reported as means ± SD (n = 5), *P < 0.05, ***P < 0.001 vs untreated control of VB 6 (Student's t test). Stimulation of NADPH/NADH (B), relative mRNA expression levels of γ-GCS (C) and total glutathione levels (D) by VB 6 . Total levels of NADPH/NADH and glutathione were measured in NHEKs treated with VB 6 for 24 h. Data are reported as means ± SD (n = 5), *P < 0.05, **P < 0.01, ***P < 0.001 vs untreated control of VB 6 (Student's t test). Relative mRNA expression levels of γ-GCS were normalized against GAPDH. Data are reported as means ± SD (n = 3), *P < 0.05 vs untreated control of VB 6 of VB 6 to improve rough skin is still unknown. Here, to demonstrate the causes of skin roughness, we first characterized the influence of highly oxidative conditions on mRNA expression levels of skin moisture-related proteins, SPT and filaggrin, in NHEKs. In general, it has been recognized that rough skin always shows skin dryness. The SC in subjects with dry skin has CPs at higher levels. [18] In addition, artificially dry skin prepared using reconstructed human epidermal equivalents (RHEEs) also shows higher levels of CPs compared with control RHEEs. [19] Furthermore, it has been reported that CPs in the SC affect the optical appearance of the skin according to the influence of skin moisturizing functions. [20, 21] In general, CPs are synthesized via the oxidation of amino residues in proteins by ROS or by an addition reaction with reactive aldehyde species generated through lipid peroxidation reaction. [22, 23] These facts indicate that highly oxidative conditions are a predominant cause of skin roughness.
We then examined the influence of highly oxidative conditions on mRNA expression levels of skin moisture-related genes in NHEKs. Oxidative conditions prepared by treatment with BSO down-regulated SPT mRNA expression, but did not alter filaggrin mRNA expression. BSO suppresses GSH synthesis by specifically inhibiting γ-GCS. [15] SPT is a rate-limiting enzyme in the synthesis of sphingosine, which is a long-chain base in ceramide. These results suggest that a decrease in ceramides due to the down-regulation of SPT is one cause that induces skin roughness.
The pharmacological effects of VB 6 to treat skin roughness were then examined focusing on releasing NHEKs from highly oxidative conditions. VB 6 restored the down-regulation of SPT mRNA expression and concomitantly reduced levels of intracellular CPs in NHEKs treated with BSO. Interestingly, VB 6 reduced levels of CPs in NHEKs in physiological conditions. These results suggested the possibility that VB 6 stimulates the intracellular antioxidant system. We propose that one possibility for the pharmacological effects of VB 6 to treat skin roughness is due to its stimulation of the intracellular antioxidant system.
In further study, we investigated the stimulation pathways of VB 6 on the intracellular antioxidant system. In general, it is well known that VB 6 is a coenzyme in the biosynthesis of niacin and is thus expected to increase the levels of NADH and NADPH. We detected increased levels of NADPH/NADH in NHEKs treated with VB 6 utilizing the reduction of resazurin to resorufin ( Figure 3B ).
On the other hand, the intracellular antioxidant system is regulated by the Nrf-2-Kelch-like ECH-associated protein 1 (Keap1)
pathway. [24] The activation of Nrf2 stimulates the intracellular antioxidant system, [25] which includes γ-GCS, glutathione peroxidase, thioredoxin, thioredoxin reductase, heme oxigenase-1 and NAD(P)H quinone oxidoreductase-1. VB 6 up-regulated the mRNA expression level of Nrf2 and also stimulated the nuclear translocation of Nrf2. As a result, we found that VB 6 increased the amount of total intracellular glutathione by inducing γ-GCS mRNA expression. Furthermore, the increase in NADPH/NADH was expected to accelerate the recycling of GSH by acting as a coenzyme of GSH reductase.
The sum of these results demonstrates that VB 6 enhances the intracellular antioxidant system through the activation of Nrf2 signalling and the increase in NADPH/NADH. We conclude that the pharmacological effect of VB 6 to treat skin roughness is due to its stimulation of the intracellular antioxidant system.
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